Company intelligence / Profile preview

AWR ProGen

Heidelberg, Baden-Württemberg, Germany

Ownership: Private
Development stage: Other

Overview

PROGEN is an established manufacturer and supplier of antibodies, recombinant proteins, ELISA kits (notably for AAV titration), density gradient media, and lipid nanoparticle delivery systems used in gene therapy research[1][3][4][5]. The company is DIN EN ISO 13485 certified since 2010[1], with products widely published in biomedical literature[5]. It serves academic labs, biotech/pharma companies, and clinical laboratories globally.

Modalities: AntibodyRecombinant proteinELISA kitLipid nanoparticle delivery system (for gene therapy research)
Industry: Protein Biomarker Diagnostics

Partnerships

Collaborations with academic institutions worldwide since at least 1983[1]Partnerships with global distributors (e.g., Dakewe BioTech Co., R-Biopharm China)[6]

Beyond the preview

Go deeper on AWR ProGen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AWR ProGen.

Explore the full profile